
Jonathan Maurer from the University of Geneva, Switzerland describes using HILIC for oligonucleotide analysis in practice and the role of HILIC for other biopharmaceutical applications.

Jonathan Maurer is a post-doctoral researcher at the Institute of Pharmaceutical Sciences of Western Switzerland (ISPSO), University of Geneva, working in the group led by Prof Davy Guillarme. His research focuses on developing advanced chromatographic methods for characterizing nucleic acid-based drug products in collaboration with Sanofi's mRNA Center of Excellence. He completed his Ph.D. at the University of Lausanne, where he specialized in mass spectrometry quantification of endogenous peptides and their clinical relevance. Jonathan has authored 15+ publications in high-impact journals (h-index 8), presented at international conferences, and received over CHF 125,000 in research funding. He is actively involved in scientific communities, serving as a board member of the ccCTA, as the founder and president of its Young Scientists’ Club, and as a regular reviewer for leading journals. Passionate about analytical chemistry and innovation, his work bridges academia and industry to advance pharmaceutical science.

Jonathan Maurer from the University of Geneva, Switzerland describes using HILIC for oligonucleotide analysis in practice and the role of HILIC for other biopharmaceutical applications.

Jonathan Maurer from the University of Geneva, Switzerland describes some of the challenges and misconceptions surrounding hydrophilic interaction chromatography (HILIC) and oligonucleotide analysis.